“The compound SR-17018 is the very first biased agonist in the mu opioid receptor that does not lead to tolerance with chronic use,” suggests Stahl, a senior team scientist from the Bohn lab. “That is a fascinating attribute for prospective use during the context of Long-term, intense agony.” HealingEnergy14 https://claytonqaipy.blogkoo.com/the-smart-trick-of-sr-17018-dosage-that-no-one-is-discussing-54966055